TP53 and prostate carcinoma: Prostate cancer research has focused on the relationship that ROS—which is generated in inflammatory processes, in the case of insufficient supply of antioxidant compounds, as a result of aging, or as a result of the action of certain genes (p53) or hormones (androgens)—has with the development of this cancer.